Table of Contents

company-logo

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

Immuneering Dividend Announcement

• Immuneering does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Immuneering dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Immuneering Dividend History

Immuneering Dividend Yield

Immuneering current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Immuneering stock? Use our calculator to estimate your expected dividend yield:

Immuneering Financial Ratios

P/E ratio-1.10
PEG ratio-0.01
P/B ratio1.11
ROE-79.19%
Payout ratio0.00%
Current ratio7.99
Quick ratio7.99
Cash Ratio0.01

Immuneering Dividend FAQ

Does Immuneering stock pay dividends?
Immuneering does not currently pay dividends to its shareholders.
Has Immuneering ever paid a dividend?
No, Immuneering has no a history of paying dividends to its shareholders. Immuneering is not known for its dividend payments.
Why doesn't Immuneering pay dividends?
There are several potential reasons why Immuneering would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Immuneering ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Immuneering has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Immuneering a dividend aristocrat?
Immuneering is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Immuneering a dividend king?
Immuneering is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Immuneering a dividend stock?
No, Immuneering is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Immuneering stocks?
To buy Immuneering you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Immuneering stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.